NEUROCRINE BIOSCIENCES INC (NBIX) Stock Cash Flow
NASDAQ:NBIX - Nasdaq - US64125C1099 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 385.90M | 249.70M | 154.50M | 89.60M | 407.30M | |||
| Depreciation Amortization | 25.70M | 21.30M | 15.60M | 10.90M | 8.60M | |||
| Income Taxes - Deferred | -71.20M | -56.70M | 19.10M | 4.30M | -310.70M | |||
| Change In Working Capital | -167.20M | 28.20M | -67.40M | 16.70M | -37.90M | |||
| Interest Paid | N/A | 3.80M | 6.60M | 8.60M | 11.60M | |||
| Taxes Paid | 191.00M | 51.50M | 14.40M | 5.10M | 15.30M | |||
| Other non cash items | 303.20M | 147.40M | 217.60M | 135.00M | 161.20M | |||
| OPERATING CASH FLOW | 476.40M | 389.90M | 339.40M | 256.50M | 228.50M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -36.30M | -28.30M | -16.50M | -23.40M | -10.90M | |||
| Other Investing Activity | -224.00M | -438.80M | -160.60M | -106.80M | 15.00M | |||
| INVESTING CASH FLOW | -260.30M | -467.10M | -177.10M | -130.20M | 4.10M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | -279.00M | -100.00K | -186.90M | |||
| Stock Issued/Repurchased | 147.50M | 65.30M | 44.70M | 27.50M | 29.10M | |||
| FINANCING CASH FLOW | -161.30M | 65.30M | -234.30M | 27.40M | -157.80M | |||
| Exchange Rate Effect | N/A | 300.00K | -1.30M | N/A | N/A | |||
| CHANGE IN CASH | 55.40M | -11.60M | -73.30M | 153.70M | 74.80M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 476.40M | 389.90M | 339.40M | 256.50M | 228.50M | |||
| Capital Expenditure | -36.30M | -28.30M | -16.50M | -23.40M | -10.90M | |||
| FREE CASH FLOW | 440.10M | 361.60M | 322.90M | 233.10M | 217.60M | |||
All data in USD